Stanford University
Showing 11,421-11,440 of 36,312 Results
-
Ruwan Gunaratne
Instructor, Medicine - Hematology
BioRuwan Gunaratne, MD, PhD is an Instructor in Hematology at Stanford University School of Medicine and a board-certified hematologist-oncologist with a clinical focus on acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs). His clinical and translational research centers on improving disease monitoring in myeloid cancers using personalized circulating tumor DNA (ctDNA) profiling, a blood-based approach designed to more sensitively track measurable residual disease (MRD), assess treatment response, refine risk stratification, and detect relapse earlier across the myeloid disease spectrum. Dr. Gunaratne’s work has been recognized with awards from the American Society of Hematology and the Stanford Cancer Institute, and he is actively committed to advancing precision medicine approaches for patients with myeloid malignancies.
-
Matthew Gunther, MD, MA
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Clinical Assistant Professor (By courtesy), Medicine - Primary Care and Population HealthCurrent Research and Scholarly InterestsDr. Gunther’s scholarly work focuses on neuropsychiatric syndromes arising in the context of medical illness, with particular emphasis on delirium, catatonia, psychopharmacology in the medically ill, and the psychiatric sequelae of critical illness. His research spans the identification, assessment, and management of acute brain dysfunction in hospitalized and critically ill populations, including studies evaluating delirium prediction tools, bedside diagnostic instruments, and neurorecovery outcomes following medical insults. He has contributed to the validation and clinical application of the Stanford Proxy Test for Delirium (S-PTD) and related delirium risk stratification efforts, and has authored systematic reviews and case-based scholarship addressing catatonia, alcohol withdrawal syndromes, and medication-related neurotoxicity. In parallel, Dr. Gunther’s work in integrated behavioral health and medical education examines how psychiatry-led, skills-based interventions can improve recognition of neuropsychiatric and trauma-related symptoms in primary care and inpatient medical settings. Across these domains, his research emphasizes translational, clinically grounded approaches that equip non-psychiatric clinicians to manage complex neuropsychiatric presentations with greater confidence and precision.
